302 related articles for article (PubMed ID: 22936343)
1. Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis.
Zhang L; Reue K; Fong LG; Young SG; Tontonoz P
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2541-6. PubMed ID: 22936343
[TBL] [Abstract][Full Text] [Related]
2. Targeted disruption of the idol gene alters cellular regulation of the low-density lipoprotein receptor by sterols and liver x receptor agonists.
Scotti E; Hong C; Yoshinaga Y; Tu Y; Hu Y; Zelcer N; Boyadjian R; de Jong PJ; Young SG; Fong LG; Tontonoz P
Mol Cell Biol; 2011 May; 31(9):1885-93. PubMed ID: 21343340
[TBL] [Abstract][Full Text] [Related]
3. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor.
Zelcer N; Hong C; Boyadjian R; Tontonoz P
Science; 2009 Jul; 325(5936):100-4. PubMed ID: 19520913
[TBL] [Abstract][Full Text] [Related]
4. Deubiquitylase Inhibition Reveals Liver X Receptor-independent Transcriptional Regulation of the E3 Ubiquitin Ligase IDOL and Lipoprotein Uptake.
Nelson JK; Cook EC; Loregger A; Hoeksema MA; Scheij S; Kovacevic I; Hordijk PL; Ovaa H; Zelcer N
J Biol Chem; 2016 Feb; 291(9):4813-25. PubMed ID: 26719329
[TBL] [Abstract][Full Text] [Related]
5. The LXR-IDOL axis defines a clathrin-, caveolae-, and dynamin-independent endocytic route for LDLR internalization and lysosomal degradation.
Sorrentino V; Nelson JK; Maspero E; Marques ARA; Scheer L; Polo S; Zelcer N
J Lipid Res; 2013 Aug; 54(8):2174-2184. PubMed ID: 23733886
[TBL] [Abstract][Full Text] [Related]
6. The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2.
Hong C; Duit S; Jalonen P; Out R; Scheer L; Sorrentino V; Boyadjian R; Rodenburg KW; Foley E; Korhonen L; Lindholm D; Nimpf J; van Berkel TJ; Tontonoz P; Zelcer N
J Biol Chem; 2010 Jun; 285(26):19720-6. PubMed ID: 20427281
[TBL] [Abstract][Full Text] [Related]
7. Regulation of intestinal LDLR by the LXR-IDOL axis.
van Loon NM; van Wouw SAE; Ottenhoff R; Nelson JK; Kingma J; Scheij S; Moeton M; Zelcer N
Atherosclerosis; 2020 Dec; 315():1-9. PubMed ID: 33190106
[TBL] [Abstract][Full Text] [Related]
8. Post-transcriptional regulation of lipoprotein receptors by the E3-ubiquitin ligase inducible degrader of the low-density lipoprotein receptor.
Sorrentino V; Zelcer N
Curr Opin Lipidol; 2012 Jun; 23(3):213-219. PubMed ID: 22510808
[TBL] [Abstract][Full Text] [Related]
9. Distinct functional domains contribute to degradation of the low density lipoprotein receptor (LDLR) by the E3 ubiquitin ligase inducible Degrader of the LDLR (IDOL).
Sorrentino V; Scheer L; Santos A; Reits E; Bleijlevens B; Zelcer N
J Biol Chem; 2011 Aug; 286(34):30190-9. PubMed ID: 21734303
[TBL] [Abstract][Full Text] [Related]
10. Reduced VLDL clearance in Apoe(-/-)Npc1(-/-) mice is associated with increased Pcsk9 and Idol expression and decreased hepatic LDL-receptor levels.
Ishibashi M; Masson D; Westerterp M; Wang N; Sayers S; Li R; Welch CL; Tall AR
J Lipid Res; 2010 Sep; 51(9):2655-63. PubMed ID: 20562239
[TBL] [Abstract][Full Text] [Related]
11. Transgenic expression of dominant-active IDOL in liver causes diet-induced hypercholesterolemia and atherosclerosis in mice.
Calkin AC; Lee SD; Kim J; Van Stijn CM; Wu XH; Lusis AJ; Hong C; Tangirala RI; Tontonoz P
Circ Res; 2014 Aug; 115(4):442-9. PubMed ID: 24935961
[TBL] [Abstract][Full Text] [Related]
12. Structural analysis of the LDL receptor-interacting FERM domain in the E3 ubiquitin ligase IDOL reveals an obscured substrate-binding site.
Martinelli L; Adamopoulos A; Johansson P; Wan PT; Gunnarsson J; Guo H; Boyd H; Zelcer N; Sixma TK
J Biol Chem; 2020 Sep; 295(39):13570-13583. PubMed ID: 32727844
[TBL] [Abstract][Full Text] [Related]
13. The LXR-Idol axis differentially regulates plasma LDL levels in primates and mice.
Hong C; Marshall SM; McDaniel AL; Graham M; Layne JD; Cai L; Scotti E; Boyadjian R; Kim J; Chamberlain BT; Tangirala RK; Jung ME; Fong L; Lee R; Young SG; Temel RE; Tontonoz P
Cell Metab; 2014 Nov; 20(5):910-918. PubMed ID: 25440061
[TBL] [Abstract][Full Text] [Related]
14. The Deubiquitylase USP2 Regulates the LDLR Pathway by Counteracting the E3-Ubiquitin Ligase IDOL.
Nelson JK; Sorrentino V; Avagliano Trezza R; Heride C; Urbe S; Distel B; Zelcer N
Circ Res; 2016 Feb; 118(3):410-9. PubMed ID: 26666640
[TBL] [Abstract][Full Text] [Related]
15. Hepatic overexpression of idol increases circulating protein convertase subtilisin/kexin type 9 in mice and hamsters via dual mechanisms: sterol regulatory element-binding protein 2 and low-density lipoprotein receptor-dependent pathways.
Sasaki M; Terao Y; Ayaori M; Uto-Kondo H; Iizuka M; Yogo M; Hagisawa K; Takiguchi S; Yakushiji E; Nakaya K; Ogura M; Komatsu T; Ikewaki K
Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1171-8. PubMed ID: 24675665
[TBL] [Abstract][Full Text] [Related]
16. Role of PCSK9 and IDOL in the pathogenesis of acquired LDL receptor deficiency and hypercholesterolemia in nephrotic syndrome.
Liu S; Vaziri ND
Nephrol Dial Transplant; 2014 Mar; 29(3):538-43. PubMed ID: 24166456
[TBL] [Abstract][Full Text] [Related]
17. Idol Depletion Protects against Spontaneous Atherosclerosis in a Hamster Model of Familial Hypercholesterolemia.
Liang C; Wang X; Peng K; Lai P; Liu Z; Ma J; Chen X; Liu G; Zheng M; Wang Y; Yang H; Liu G; Xian X; Gao M
Oxid Med Cell Longev; 2022; 2022():1889632. PubMed ID: 35656026
[TBL] [Abstract][Full Text] [Related]
18. The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor.
Zhang L; Fairall L; Goult BT; Calkin AC; Hong C; Millard CJ; Tontonoz P; Schwabe JW
Genes Dev; 2011 Jun; 25(12):1262-74. PubMed ID: 21685362
[TBL] [Abstract][Full Text] [Related]
19. IDOL stimulates clathrin-independent endocytosis and multivesicular body-mediated lysosomal degradation of the low-density lipoprotein receptor.
Scotti E; Calamai M; Goulbourne CN; Zhang L; Hong C; Lin RR; Choi J; Pilch PF; Fong LG; Zou P; Ting AY; Pavone FS; Young SG; Tontonoz P
Mol Cell Biol; 2013 Apr; 33(8):1503-14. PubMed ID: 23382078
[TBL] [Abstract][Full Text] [Related]
20. Effect of Porphyromonas gingivalis infection on post-transcriptional regulation of the low-density lipoprotein receptor in mice.
Miyazawa H; Tabeta K; Miyauchi S; Aoki-Nonaka Y; Domon H; Honda T; Nakajima T; Yamazaki K
Lipids Health Dis; 2012 Sep; 11():121. PubMed ID: 22992388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
